SAN FRANCISCO – Alyve Medical Inc. recently became one of only 200 companies worldwide to earn a coveted presentation slot at the 10th annual Venture Summit West. The Silicon Valley-based event connects founders of the hottest venture backed, emerging and early-stage companies with an exclusive audience of venture capitalists, corporate investors, private investors, investment bankers, and strategic partners.

Venture Summit West, presented by youngStartup Ventures, is the premier industry gathering for promising companies in tech, fintech, cleantech, medtech, lifesciences, and healthcare. With thousands of attendees each year and over 100 featured investors with over $250B under management, Venture Summit West is the event where significant deals are made. For Alyve Medical, it is an opportunity to connect with investors, share their vision, and secure the funding they need to continue their important work.

“I am thrilled to present at such an exclusive event to share the great potential of Alyve Medical and our innovative products, Neuralign S™ and ShowMotion™”, noted Yvonne Bokelman, Alyve Medical’s Chief Executive Officer. “This is a unique opportunity to increase the visibility of Alyve Medical and to secure funding to allow us to scale our operations in order to enable broader access to our solutions for patients and healthcare providers in the US and around the globe.”

Venture Summit West accepts presenters who meet strict criteria based on industry, stage, business model, size of the target audience, milestones achieved to date, and whether the company would be of interest to the featured investors. The presentation programs are geared toward emerging growth companies looking to gain visibility among active investors and raise capital. Companies looking to secure series A-C funding for $2-30M are eligible for the Top Innovators Program, while seed stage companies can apply for the Seed Pitchfest Program.

To learn more about Alyve Medical, visit https://alyvemedical.com/.